6:30pm Friday, December 13, 2013

With Special Honorees
Antonio Colombo, MD
Runlin Gao, MD
Patrick W. Serruys, MD, PhD
J. Eduardo Sousa, MD, PhD

The Gala

Heart disease is the number one cause of death globally and affects millions around the world. The Cardiovascular Research Foundation (CRF) is dedicated to improving the survival and quality of life for people suffering from cardiovascular disease through research and education. This year’s Gala recognizes the essential global collaborations that have made advancements and improvements in cardiovascular medicine possible and the international partnerships that have played pivotal roles in improved outcomes for patients all over the world.

6:30 pm · Friday, December 13, 2013

Co-Chairs

Martin B. Leon, MD
Gregg W. Stone, MD

The Plaza

The Grand Ballroom
Fifth Avenue at Central Park West
New York, NY

For more information, please contact Irma Damhuis at 646-434-4690 or idamhuis@crf.org

the gala

Honorees

Antonio Colombo, MD

Antonio Colombo, MD is an expert interventional cardiologist from Italy with extensive experience in coronary stenting, peripheral vascular interventions and the treatment of structural heart disease, including transcatheter aortic valve implantation and mitral interventions. He has made many seminal contributions to the development of techniques and pharmacology related to coronary stenting. Dr. Colombo currently serves as Director of Cardiovascular Interventions in San Raffaele Scientific Institute at Columbus Hospital in Milan, Italy.

Runlin Gao, MD

Runlin Gao, MD has been engaged in clinical practice and interventional cardiology research for more than 45 years. As one of China’s pioneers in the field, he was the first to perform percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial infarction and cardiogenic shock in China. He also completed the first reported coronary stenting, intravascular brachytherapy and drug-eluting stent implantation. Dr. Gao has devoted his career to educating and training his colleagues, as well as leading experimental and clinical studies on new drug-eluting and bioabsorbable stents. He is a Professor of Medicine and Chief Cardiologist at Cardiovascular Institute and Fu Wai Hospital in Beijing.

Patrick W. Serruys, MD, PhD

Patrick W. Serruys, MD, PhD has dedicated his life to improving the treatment of patients with cardiovascular disease through his contributions to the field of percutaneous cardiovascular intervention, especially in the development of and improvements to bare-metal and drug-eluting stents. Recognized worldwide for his major contributions to interventional cardiology, Dr. Serruys is the author or coauthor of over 1,600 papers and editor or coeditor of 37 books, and a member of 20 Editorial Boards of scientific journals. He currently serves as Director of the Clinical Research Program of the Catheterization Laboratory in the Thorax Center at Erasmus University, and Head of the Interventional Department, Thorax Center, Erasmus MC (University Medical Center Rotterdam) in Rotterdam, The Netherlands.

J. Eduardo Sousa, MD, PhD

J. Eduardo Sousa, MD, PhD has played a pivotal role in interventional cardiology bringing the field a greater understanding of the mechanisms of stent deployment and restenosis. As General Director of the Institute Dante Pazzanese of Cardiology in Sao Paulo, Brazil, he oversaw the starting point of a new era in interventional cardiology in 1987 when his group implanted the first balloon expandable stent in a human coronary artery. More recently, he helped conduct the first-in-man (FIM) experience with sirolimus-eluting stents.

2012 Photo Gallery

Attend the Gala

To reserve a table or purchase tickets, please complete the online form below.

Premier Table: $50,000: Includes premier seating for 10, VIP reception, special recognition in program and from podium at the event, including digital advertisement, and Web link with company name and logo on CRF Web site for 1 year.

Leadership Table: $25,000: Includes premium seating for 10, special recognition in program, special recognition from podium and at event including digital advertisement.

Benefactor Table: $15,000 (Limited Availability) Includes priority seating for 10 and special recognition in program.

Patron Ticket: $1,750: Includes preferred seating and recognition in program.

Individual Ticket: $1,000

Digital Advertisement: $2,500 (per ad)

Contact Information
For more information, please contact Judy Romero at 646-434-4608 or jromero@crf.org.



About CRF

Since its inception in 1991, the Cardiovascular Research Foundation (CRF) has played a major role in realizing dramatic improvements in treating heart disease by establishing the safe use of new technologies, drugs, and therapies in interventional cardiovascular medicine. Guided by visionary physicians who are passionate about advancing the field, CRF’s mission is to improve the survival and quality of life for those suffering from heart disease around the world.

CRF’s role in interventional cardiovascular medicine is unique. By providing research, evaluation, and education under one roof, CRF has the ability to generate important research questions, test and refine groundbreaking new therapies, and ensure that these treatments are available to patients at the earliest opportunity.

For more information, please visit www.crf.org.



CRF Logo